Drug injury lawsuits seeking compensation for patients with Wegovy and Ozempic eye damage side effects have been filed against the pharmaceutical company Novo Nordisk.
These Wegovy and Ozempic eye damage lawsuits have received a boost, it seems, from some recent news out of Europe. From this November 21, 2025, article, “Denmark compensates patients for vision loss linked to Novo Nordisk drugs“:
Four patients in Denmark, who experienced vision loss after using Novo Nordisk’s (NOVOb.CO) popular weight-loss and diabetes drugs Wegovy and Ozempic, have been granted compensation, the Danish Patient Compensation association said on Friday.
The two drugs, which contain the active ingredient semaglutide, have been linked in very rare cases to a serious eye condition known as non-arteritic anterior ischemic optic neuropathy (NAION), the European Medicines Agency’s safety committee noted in June. The condition can cause permanent vision loss.
To “connect the dots” so you can better understand the significance of this November 2025 news report about Wegovy and Ozempic eye damage compensation paid in Europe, we provide these six points as background information:
- Semaglutide has been linked to non-arteritic anterior ischemic optic neuropathy (NAION) by several medical studies.
- Wegovy and Ozempic, as well as Rybelsus, are Novo Nordisk drugs with semaglutide as their active ingredient.
- The semaglutide side effect NAION causes eye damage, resulting in sudden vision loss, and can lead to blindness.
- There are no proven medical treatments for NAION at present, and the eye damage sometimes gets worse with the passage of time.
- The current Rybelsus, Wegovy, and Ozempic drug labels in the US do not have any warnings about NAION as an eye-related side effect.
- The lawsuits filed against Novo Nordisk allege a failure to warn doctors and patients about the risks of eye damage, including NAION.
We have been covering the legal and medical developments concerning Wegovy and Ozempic eye damage side effects since July 2024, as seen by these Drug Injury Law articles listed in latest-to-earliest order:
- Ozempic NAION Rate Higher in Recent 2025 Medical Study
- Ozempic and Mounjaro Increased Risk of NAION More Than Other Diabetes Drugs
- Link Between Ozempic and NAION Also Involves the Eye Disorder AION
- Ozempic Blindness Legal Cases Filed Against Novo Nordisk in April 2025
- Vision Loss Linked to Ozempic and Rybelsus Use by Diabetes Patients
- Ozempic Eye Problems Caused by Semaglutide-Related NAION
- Ozempic Linked to Vision Loss With Increased Risk of NAION Side Effect
- Ozempic Side Effects Include Eye Problems With Possible Vision Loss
If you or someone you know has suffered eye damage while using Ozempic, Wegovy, or Rybelsus, consider submitting an online Case Evaluation Form specific to these cases. In turn, attorney Tom Lamb can evaluate the situation as a possible drug injury lawsuit and respond to you no later than the next business day. Or you can call Mr. Lamb at 910-256-2971 to discuss the vision loss or blindness situation with him.
Ozempic / Rybelsus / Wegovy
Free Case Evaluation
Strictly Confidential, No Obligation